Epithelial Cell Transforming Sequence 2 Oncogene (ECT2) Peptid
ECT2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939857
Kurzübersicht für Epithelial Cell Transforming Sequence 2 Oncogene (ECT2) Peptid (ABIN939857)
Target
ECT2
(Epithelial Cell Transforming Sequence 2 Oncogene (ECT2))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- KKHTADENPD KSTLEKAIGS LKEVMTHINE DKRKTEAQKQ IFDVVYEVDG
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ECT2 antibody,
Alternative Names: ECT2 control peptide, ECT2 antibody Blocking Peptide, Anti-ECT2 Blocking Peptide, Epithelial Cell Transforming Sequence 2 Oncogene Blocking Peptide, FLJ10461 Blocking Peptide, MGC138291 Blocking Peptide, ECT2, ECT-2, ECT 2, ECT-2 Blocking Peptide, ECT 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- ECT2 (Epithelial Cell Transforming Sequence 2 Oncogene (ECT2))
-
Hintergrund
- ECT2 is a transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of ECT2 is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis.
-
Molekulargewicht
- 100 kDa
Target
-
Sie sind hier:
